MeSH D009120 - muscle cramp
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Cyclobenzaprine | Amrix | 2023-11-14 | 2007-02-01 |  |  |
| Methocarbamol | Methocarbamol |  | 1982-01-01 |  |  | |
| Aspirin, Methocarbamol | Methocarbamol Aspirin |  | 1982-12-22 |  |  | |
| Novast Laboratories | Cyclobenzaprine | Cyclobenzaprine |  | 2024-08-27 |  |  |
| Mylan | Methocarbamol | Methocarbamol |  | 1982-01-01 |  |  |
| Johnson & Johnson | Cyclobenzaprine | Flexeril |  | 1982-01-01 |  |  |
| Cipla | Cyclobenzaprine | Cyclobenzaprine |  | 2010-07-23 |  |  |
| Lupin Research | Orphenadrine | Orphenadrine |  | 1998-06-19 |  |  |
| Sandoz | Cyclobenzaprine | Cyclobenzaprine |  | 1993-02-26 |  |  |
| Methocarbamol | Methocarbamol |  | 1982-01-01 |  |  | |
| Orphenadrine | Orphenadrine |  | 2000-02-15 |  |  | |
| Aspirin, Caffeine, Orphenadrine | Orphenadrine Citrate, Aspirin, Caffeine |  | 1996-12-31 |  |  | |
| Aspirin, Codeine, Carisoprodol | Carisoprodol, Aspirin Codeine |  | 1996-04-16 |  |  | |
| Chartwell Pharmaceuticals | Aspirin, Caffeine, Orphenadrine | Invagesic |  | 1996-11-27 |  |  |
| Cyclobenzaprine | Cyclobenzaprine |  | 2008-04-18 |  |  | |
| Methocarbamol | Methocarbamol |  | 1982-01-01 |  |  | |
| 3M | Orphenadrine | Disipal |  | 1982-01-01 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/1
Phase 2
0%0/2
Phase 3
92%11/12
Approved: 10Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use